Navigation Links
BioScrew® Bio-Absorbable Interference Screws

ProductsBioScrew® Bio-Absorbable Interference Screws
Company Linvatec Corporation (now ConMed)
Item BioScrew® Bio-Absorbable Interference Screws
Features 
  • Made of Poly (L-Lactic Acid), the screw is gradually absorbed and eventually disappears
  • BioScrew® screws have a long-term absorption rate which ensures secure graft fixation throughout the healing process
  • Any future revision surgery is free of implant removal complications because the screw is absorbed or can simply be overdrilled
  • BioScrew® screws are packaged sterile, single use
  • The BioScrew® tri-lobe accepts the Guardsman® graft protector as an optional protective barrier between the screw and graft
  • Description BioScrew® Bio-Absorbable Interference Screws and Delivery System Clinically equivalent to metal interference screws.
    Info Linvatec Corporation (now ConMed)
    Customer Service: (800) 237-0169
    Web site: http://www.conmed.com/linvatec.php

    Related medicine products :

    1. PHANTOM Absorbable Cannulated Interference Screws
    2. PHANTOM SofThread Cannulated Interference Screws
    3. ADVANTAGE Titanium Cannulated Interference Screws
    4. PROFILE Titanium Cannulated Interference Screws
    5. ABSOLUTE Absorbable Cannulated Interference Screws
    6. Propel Cannulated Interference Screw
    7. BIG ADVANTAGE Cannulated Titanium Interference Screws
    8. Interference Screws
    9. Guardsman Femoral Interference Screw
    10. Cannulated Interference Screws
    11. Gentle Threads Interference Screws
    ...e used for arthroscopic or open procedures such as...ral or tibial fracture management. The system atta...table.,The Delrin horizontal post is radioluc...n. Foam post padding provides a safe, posterior kn...
    ...g nailing, repairs and fractures. Designed to pos...ullary nailing of the tibia, ligament repairs and ...ter than 90 to allow reaming and nail insertion wi...able in three heights, 11", 14", and 16". The two ...
    ...oabsorbable PLLA screw post for suture or soft tis... The tapered 35 mm length and cancellous screw des...llous bone. Ideal screw length can be intraoperati... Rongeur if necessary.,Each sterile screw com...
    Wixson/Stulberg Anterior Trunk Support
    Medicine Products:
    (Date:11/7/2009)... In the current economic climate,...losely and are only spending money on what that th...ight loss surgeon David D. Kim believes that it&r... and women to receive treatment to improve their h...y affordable to patients in this tough economy by ...
    (Date:11/7/2009)... A new foot spray from Greensatio...power of hot peppers and caffeine. ThermaFeet targ... formula that also contains Black Walnut, Goldense... Schenectady, NY (PRWEB) November 7...s pain and increases circulation with the power of...
    (Date:11/6/2009)..., Nov. 6 Recently a Narconon of Georgia graduate ...ence with prescription drug abuse. The special rep... drug addiction . In the report Andrew shared ... should be done to prevent prescription drug abuse... knew I opened my eyes to my father on top of me g...
    (Date:11/6/2009)... endorses House health bill loaded with pledge-bre...wing was released today by Americans for Tax Refor...re bill today, President Barack Obama effectively ...paign was a lie. ,, During the campaign, Obama ma...taxes on families making less than $250,000 per ye...
    (Date:11/6/2009)...IS, Nov. 6 Centene Corporation (NYSE: CNC ) toda...ealthcare conferences over the next few weeks. ,, ... Care Conference, to be held November 11-13, 2009,..., Centene will present Wednesday, November 11th at...rested parties may access Centene,s presentation a...
    Breaking Medicine News(10 mins):Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
    ...17 ANSYS, Inc.,(Nasdaq: ANSS ), a global innovat...d to optimize product development processes, today...ir Time exhibit at the Carnegie Museum of,Natural ...f original fossil specimens. It is unique in that ...
    ...17 Hillenbrand,Industries, Inc. (NYSE: HB ) (the...ts of its previously announced cash tender offer t...cent Senior Notes due 2009 (CUSIP,No. 431573AD6), ...rchase dated February 29, 2008 (the "Offer to,Purc...
    ...VANCOUVER, March 17 /PRNewswire-FirstCall/ - Cardi...ounced positive interim clinical results,from its ...nterim analysis,demonstrated statistically signifi...o suggests that vernakalant (oral),was well-tolera...
    ...h 17 Researchers will unveil a,new brain fitness ...rous,published studies to help people maintain hea...mance of daily living tasks essential to,independe...), at the annual International Long Term Care Insu...
    ...igational antiviral drug currently undergoing huma...ions may have potential to reduce muscle cell dama...hy (MD). A research team led by Cincinnati Childre...dicine. , The investigational drug, Debio-025, is...
    ...ontribute to weight gain, experts say, , ,...y to weight loss for some people be as simple as g...ch suggests that people who don,t get enough sleep... proper sleep and proper health. Sleep deprivatio...
    Other Medicine News:Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 2Health News:ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History 3Health News:Hillenbrand Industries, Inc. Announces Early Tender Results of its Pending 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces Early Tender Results of its Pending 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 3Health News:Hillenbrand Industries, Inc. Announces Early Tender Results of its Pending 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 4Health News:Hillenbrand Industries, Inc. Announces Early Tender Results of its Pending 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 5Health News:Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor 2Health News:Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor 3Health News:Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor 4Health News:Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor 5Health News:Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor 6Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 2Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 3Health News:Investigational drug tested for preventing muscle fiber death in muscular dystrophy 2Health News:Investigational drug tested for preventing muscle fiber death in muscular dystrophy 3Health News:Starved for Sleep? Watch Your Waistline 2Health News:Starved for Sleep? Watch Your Waistline 3
    (Date:11/6/2009).... 6 Ardea Biosciences, I...sed on the development of small-molecule therapeut...munodeficiency virus (HIV), today reported recent ...d quarter and nine months ended September 30, 2009...rnh/20091104/ARDEALOGO ) ,, "Since our last qua...
    (Date:11/6/2009)...6 GeoVax Labs, Inc. (OT..."), an Atlanta-based, biopharmaceutical company de...-1 (Human Immunodeficiency Virus) and other infect...9 financial results and provided an operational up...hief Executive Officer commented, "We are pleased ...
    (Date:11/6/2009)...ember 6 , - Trial Will Co... the,Treatment of Multi-Resistant Staphylococcus A...iality pharmaceutical company focused on the disco... to overcome the significant global,problem of mic...dvanced oral,antibacterial NXL103 (flopristin/lino...
    Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Major discovery opens door to leishmania treatment 10276 1Major discovery opens door to leishmania treatment 10276 2GlobalSubmit Extends Signature Partnership Program 58987 1GlobalSubmit Extends Signature Partnership Program 58987 2Lilly Confirms Date and Conference Call for Third Quarter 2009 Financial Results Announcement 58983 1